Delivery Order SPE2DB24D2003-SPE2DB25FXLN2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,438.54 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on July 21, 2025, with an ultimate completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a $3,055.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Opzelura 1.5% cream (60gm) on August 7, 2025, with completion scheduled for August 8, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,725.99 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60gm), a pharmaceutical product to be delivered to the company's facility in Conshohocken, Pennsylvania. This non-set-aside, firm fixed price delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. The award represents a child contract action under AmerisourceBergen's broader relationship with the federal government as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,460.52 for Opzelura 1.5% Cream (60 grams) with a completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $1 billion through December 2026. The contract carries no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 5, 2025, for the supply of Opzelura 1.5% Cream in 60-gram quantities. The contract is valued at $14,900.19 and carries a firm fixed price structure with no set-aside designation, indicating it was awarded through open competitive procurement. Performance will be completed by August 6, 2025, with work performed...
- The Defense Logistics Agency awarded a delivery order valued at $2,909.76 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM), a topical pharmaceutical product. This non-set-aside, competitively awarded contract features firm fixed pricing and was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, valued at $4,813.05. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The order is scheduled for ultimate completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,006.28 to AmerisourceBergen Drug Corp for the supply of OPZELURA 1.5% Cream (60GM), a pharmaceutical product. This non-competitive, firm fixed-price delivery order was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,335.40, is for the delivery of Opzelura 1.5% cream, a pharmaceutical product, to DLA. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 9, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLN2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,358.40 to AmerisourceBergen Drug Corp for Opzelura 1.5% Cream (60 grams) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies routine pharmaceutical procurement through the company's existing federal contract vehicle, which supplies a comprehensive range of medical products including brand-name and generic medications, vaccines, and specialized healthcare commodities to support military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement needs. The company's substantial IDC with DLA Troop Support Medical through December 2026 provides a flexible contracting mechanism for delivering pharmaceutical products globally to support military healthcare programs and other government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Through this arrangement, AmerisourceBergen has demonstrated the capability to fulfill federal procurement requirements across a broad spectrum of therapeutic domains, from specialty medications to medical supplies, positioning it as a key partner in the Defense Logistics Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 8/8/25 |